SCHEMBL25041353

SCHEMBL25041353

Cc1cc(NC2CCC(N)CC2)cc(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 3/20 0.38
▸ ROCK2 O75116 2/20 0.38
▸ SMYD3 Q9H7B4 4/20 0.36
▸ IRAK4 Q9NWZ3 3/20 0.36
▸ KIT P10721 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ CCNT1 O60563 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CCNH P51946 1/20 0.35
▸ ROCK1 Q13464 1/20 0.34
▸ MAPKAPK2 P49137 3/20 0.34
▸ CHEK2 O96017 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ MAPKAPK3 Q16644 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25039269 0.84 KDM4E (0.42) KDM1AROCK2SMYD3IRAK4CCNT1
SCHEMBL25039647 0.84 SMYD3 (0.37) KDM1AROCK2SMYD3IRAK4KIT
SCHEMBL25039592 0.83 KDM4E (0.46) KDM1AKITFLT3
SCHEMBL26325063 0.81 SMN1; SMN2 (0.42) —
SCHEMBL25039645 0.79 BTK (0.37) KDM1AFLT3CCNT1BTKMAOB
SCHEMBL25039410 0.77 KIT (0.40) KDM1ASMYD3IRAK4KITFLT3
SCHEMBL25041982 0.77 SMYD3 (0.40) KDM1AROCK2SMYD3KITFLT3
SCHEMBL7130956 0.76 CA12 (0.42) KDM1ASMYD3IRAK4MAOB
SCHEMBL25039260 0.76 KDM1A (0.39) KDM1AMAOB
SCHEMBL25039416 0.74 RAPGEF4 (0.46) KDM1AROCK2SMYD3IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 — — US disclosed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 — — EP disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 — — WO disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 KDM1A 3776/4885ROCK2 1973/4885SMYD3 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback